alba24.ro/noi-reguli-pentru-medicamentele-compensa

The Ministry of Health and CNAS have updated prescription rules for various subsidized medications, including treatments for cancer, high cholesterol, hepatitis C, and autoimmune diseases. New protocols were introduced for allergic rhinitis and rare diseases. The changes, published on October 21, 2026, in the Official Gazette, detail eligibility criteria, treatment administration, and patient monitoring. Specific medications affected include Cemiplimab for skin cancer, Inclisiran for high cholesterol, and updated protocols for hepatitis C treatments. The modifications aim to enhance patient access to necessary therapies while maintaining strict eligibility requirements.